Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 18/20 | 1.00 |
| ▸ | CNR1 | P21554 | 10/20 | 1.00 |
| ▸ | LDHA | P00338 | 2/20 | 1.00 |
| ▸ | TRPM8 | Q7Z2W7 | 2/20 | 1.00 |
| ▸ | DAGLA | Q9Y4D2 | 2/20 | 1.00 |
| ▸ | PPARG | P37231 | 1/20 | 1.00 |
| ▸ | ABHD12 | Q8N2K0 | 3/20 | 0.64 |
| ▸ | ABHD6 | Q9BV23 | 3/20 | 0.64 |
| ▸ | FAAH | O00519 | 2/20 | 0.64 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.64 |
| ▸ | GLRA1 | P23415 | 1/20 | 0.64 |
| ▸ | GPR183 | P32249 | 1/20 | 0.64 |
| ▸ | DRD3 | P35462 | 1/20 | 0.64 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.64 |
| ▸ | GPR18 | Q14330 | 1/20 | 0.64 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.64 |
| ▸ | NAAA | Q02083 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Delta9-Tetrahydrocannabinolic Acid A SCHEMBL6856735 | 1.00 | CNR2 (1.00) | CNR2CNR1LDHATRPM8DAGLA | |
| Delta9-Tetrahydrocannabinolic Acid A SCHEMBL18095976 | 1.00 | CNR2 (1.00) | CNR2CNR1LDHATRPM8DAGLA | |
| Delta9-Tetrahydrocannabinolic Acid A SCHEMBL16769847 | 1.00 | CNR2 (1.00) | CNR2CNR1LDHATRPM8DAGLA | |
| Delta9-Tetrahydrocannabinolic Acid A SCHEMBL14773902 | 1.00 | CNR2 (1.00) | CNR2CNR1LDHATRPM8DAGLA | |
| Delta9-Tetrahydrocannabinolic Acid A SCHEMBL29691633 | 1.00 | CNR2 (1.00) | CNR2CNR1LDHATRPM8DAGLA | |
| Delta9-Tetrahydrocannabinolic Acid A SCHEMBL29610699 | 1.00 | CNR2 (1.00) | CNR2CNR1LDHATRPM8DAGLA | |
| SCHEMBL25215172 | 0.99 | CNR2 (0.98) | CNR2CNR1LDHATRPM8DAGLA | |
| SCHEMBL23121713 | 0.99 | CNR2 (0.98) | CNR2CNR1LDHATRPM8DAGLA | |
| SCHEMBL22691773 | 0.99 | CNR2 (0.98) | CNR2CNR1LDHATRPM8DAGLA | |
| SCHEMBL23874170 | 0.99 | CNR2 (0.98) | CNR2CNR1LDHATRPM8DAGLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240026392-A1 | BIOSYNTHESIS OF CANNABINOIDS AND CANNABINOID PRECURSORS | GINKGO BIOWORKS, INC. (US) | 2024-01-25 | — | — | US | disclosed |
| US-20230340446-A1 | BIOSYNTHESIS OF CANNABINOIDS AND CANNABINOID PRECURSORS | GINKGO BIOWORKS, INC. (US) | 2023-10-26 | — | — | US | disclosed |
| US-20230137139-A1 | BIOSYNTHESIS OF CANNABINOIDS AND CANNABINOID PRECURSORS | GINKGO BIOWORKS, INC. (US) | 2023-05-04 | — | — | US | disclosed |
| US-20220195472-A1 | BIOSYNTHESIS OF CANNABINOIDS AND CANNABINOID PRECURSORS | GINKGO BIOWORKS, INC. (US) | 2022-06-23 | — | — | US | disclosed |
| US-11274320-B2 | Biosynthesis of cannabinoids and cannabinoid precursors | GINKGO BIOWORKS, INC. (US) | 2022-03-15 | — | — | US | disclosed |
| US-20210071209-A1 | BIOSYNTHESIS OF CANNABINOIDS AND CANNABINOID PRECURSORS | GINKGO BIOWORKS, INC. (US) | 2021-03-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230137139-A1 | BIOSYNTHESIS OF CANNABINOIDS AND CANNABINOID PRECURSORS | CNR1, CNR2, GGPS1 | CNR2 2/4885CNR1 1/4885LDHA 4650/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.